E J Kuipers1, S G Meuwissen. 1. Dept. of Gastroenterology, Free University Hospital, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Helicobacter pylori causes chronic persistent gastritis in virtually all infected subjects, leading to development of atrophic gastritis, intestinal metaplasia and eventually dysplasia and gastric cancer in a number of infected subjects. Based on the available evidence, an IARC monograph committee classified H. pylori as a class I carcinogen to humans. Prospective studies suggest that infection increases the risk for atrophic gastritis and gastric cancer at least 8-fold. In the presence of infection, the risk for atrophy and cancer seems higher if a subject becomes infected in early childhood, if infection occurs with a cagA positive strain, and if acid output is decreased. CONCLUSION: H.pylori is a gastric carcinogen. The clinical implications and possible strategies for cancer prevention have to be delineated in the near future.
BACKGROUND:Helicobacter pylori causes chronic persistent gastritis in virtually all infected subjects, leading to development of atrophic gastritis, intestinal metaplasia and eventually dysplasia and gastric cancer in a number of infected subjects. Based on the available evidence, an IARC monograph committee classified H. pylori as a class I carcinogen to humans. Prospective studies suggest that infection increases the risk for atrophic gastritis and gastric cancer at least 8-fold. In the presence of infection, the risk for atrophy and cancer seems higher if a subject becomes infected in early childhood, if infection occurs with a cagA positive strain, and if acid output is decreased. CONCLUSION:H.pylori is a gastric carcinogen. The clinical implications and possible strategies for cancer prevention have to be delineated in the near future.
Authors: D Basso; F Navaglia; L Brigato; M G Piva; A Toma; E Greco; F Di Mario; F Galeotti; G Roveroni; A Corsini; M Plebani Journal: Gut Date: 1998-08 Impact factor: 23.059
Authors: D Basso; A Stefani; L Brigato; F Navaglia; E Greco; C F Zambon; M G Piva; A Toma; F Di Mario; M Plebani Journal: J Clin Lab Anal Date: 1999 Impact factor: 2.352
Authors: K F To; M W Y Chan; W K Leung; E K W Ng; J Yu; A H C Bai; A W I Lo; S H Chu; J H M Tong; K W Lo; J J Y Sung; F K L Chan Journal: Br J Cancer Date: 2004-10-04 Impact factor: 7.640
Authors: Nina Bertaux-Skeirik; Rui Feng; Michael A Schumacher; Jing Li; Maxime M Mahe; Amy C Engevik; Jose E Javier; Richard M Peek; Karen Ottemann; Veronique Orian-Rousseau; Gregory P Boivin; Michael A Helmrath; Yana Zavros Journal: PLoS Pathog Date: 2015-02-06 Impact factor: 6.823